Covered recipient · General Payments record
CHRISTINA M HOLTMAN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,069.47
- Reported across 105 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $752.60 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $300.61 | 16 |
| UCB, Inc. | $117.01 | 5 |
| PFIZER INC. | $75.60 | 4 |
| ITI, Inc. | $65.65 | 3 |
| HARMONY BIOSCIENCES LLC | $61.84 | 2 |
| EISAI INC. | $44.83 | 2 |
| JAZZ PHARMACEUTICALS INC. | $30.42 | 1 |
| Lilly USA, LLC | $22.49 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.82 | 1 |
| Lundbeck LLC | $13.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.76 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351817 | CMS |
| ABBVIE INC. | $9.37 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351819 | CMS |
| ABBVIE INC. | $23.68 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351821 | CMS |
| ABBVIE INC. | $17.43 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351823 | CMS |
| ABBVIE INC. | $22.79 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351825 | CMS |
| ABBVIE INC. | $5.46 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351827 | CMS |
| ABBVIE INC. | $23.25 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351829 | CMS |
| ABBVIE INC. | $33.16 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351831 | CMS |
| ABBVIE INC. | $19.96 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351833 | CMS |
| ABBVIE INC. | $12.82 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351835 | CMS |
| ABBVIE INC. | $10.13 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351837 | CMS |
| ABBVIE INC. | $21.00 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351839 | CMS |
| ABBVIE INC. | $13.33 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351841 | CMS |
| ABBVIE INC. | $23.26 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351843 | CMS |
| ABBVIE INC. | $14.03 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351845 | CMS |
| ABBVIE INC. | $31.18 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107351847 | CMS |
| Eisai Inc. | $22.92 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110797829 | CMS |
| Eisai Inc. | $21.91 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110797831 | CMS |
| HARMONY BIOSCIENCES LLC | $34.23 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126059620 | CMS |
| HARMONY BIOSCIENCES LLC | $27.61 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126059622 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $25.32 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143500752 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14.50 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143500755 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $25.83 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143500759 | CMS |
| JAZZ PHARMACEUTICALS INC. | $30.42 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151313373 | CMS |
| Lilly USA, LLC | $22.49 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135586599 | CMS |
| Lundbeck LLC | $13.33 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146036338 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.82 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119096798 | CMS |
| PFIZER INC. | $22.17 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131290357 | CMS |
| PFIZER INC. | $13.08 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131991747 | CMS |
| PFIZER INC. | $17.49 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131068456 | CMS |
| PFIZER INC. | $22.86 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131015071 | CMS |
| UCB, Inc. | $19.79 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143400272 | CMS |
| UCB, Inc. | $20.26 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143400276 | CMS |
| UCB, Inc. | $31.28 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143400281 | CMS |
| UCB, Inc. | $22.02 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143400285 | CMS |
| UCB, Inc. | $23.66 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143400289 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.